logologo
QuantliQuantli

Alnylam Pharmaceuticals Inc

ALNY

NASDAQ

Biotechnology

$228.65

USD

+1.53 (+0.67%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $30.39B

Volume 1.5M

Price Target

$380.00$470.00

USD

The 4 analysts offering 1-year price forecasts have a max estimate of $470.00 and a min estimate of $380.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$431.25

-$0.8 vs prior

Implied Upside

+88.6%

-0.3% vs prior

Analyst Covering

4

-2 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

40%

A mix of recent and older ratings shape this consensus

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$6.25 Gap

Median $437.50 vs avg $431.25 - a few cautious outliers are pulling the average down

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

4 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

4

Hold

0

Sell

0

Strong Sell

0

4 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Eliana Merle

UBS

Buy

Maintained

1 week ago

Plus
Plus
Plus

Keay Nakae

Chardan Capital

Buy

Maintained

2 weeks ago

Plus
Plus
Plus

Patrick R. Trucchio

HC Wainwright & Co.

Buy

Maintained

1 month ago

Plus
Plus
Plus

Eric Joseph

JP Morgan

Buy

Initiated

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

RVMD

Revolution Medicines Inc

$203.71

+0.8%

UTHR

United Therapeutics Corp

$499.73

-0.3%

BIIB

Biogen Inc

$209.83

-0.4%

BBIO

BridgeBio Pharma Inc

$79.86

-1.7%

MRNA

Moderna Inc

$63.32

-0.5%

REGN

Regeneron Pharmaceuticals Inc

$803.48

-0.3%

INCY

Incyte Corp

$120.16

-0.3%

INSM

Insmed Inc

$123.74

-2.0%

NTRA

Natera Inc

$309.93

-0.3%